Seeking women and men who have started ocrelizumab treatment for their Multiple Sclerosis (MS) within the past month or people whose MS is being being treated with therapies other than ocrelizumab for a study looking at the incidence of cancer in the future.
4 Studies found
The study is open to men & women with triple negative breast cancer that have received chemotherapy prior to surgery, then had surgery to remove the breast cancer, and viable tumor was still seen in the surgery specimen.
Seeking men & women 18 - 70 years who have a history of node positive or high risk node negative breast cancer.
This study is comparing two types of screening mammograms, Digital Mammograms and Tomosynthesis Mammograms, to see which is better for breast cancer screening.